RE:RE:How much longer do we wait?I think it's more a "not if, but when?" If shareholder feel their money is tied up to long or investment is to risky, move on. No one, nor those at THRM, probably know timelines from FDA. BUT.. Biden Admin is seriously pressuring FDA to be quick in rapid test validation and authorization, per many many announcements last week. And the potential to be the only saliva test on this FDA EUA Antigen List from the other 23 companies nasal tests makes has me holding tight to my shares... I'm staying. Doubt I, or anyone here, can find any better potential high risk investment return on the near horizon than where the THRM stock price resides right now C$0.40. Be that return be a week to a few months. JMHO. GLTA